FDA IT Infrastructure Inadequate For Managing Foreign Inspections, GAO Says
Executive Summary
FDA's ability to oversee drug importation is encumbered by an inaccurate and dysfunctional information technology infrastructure, the Government Accountability Office asserts
You may also be interested in...
FDA’s Dubious Honor: GAO Flags Many Of Its Activities As “High Risk”
FDA's White Oak campus is still far from complete, but an extreme reading of official statements during the last few weeks might suggest that it could be closed
FDA’s Dubious Honor: GAO Flags Many Of Its Activities As “High Risk”
FDA's White Oak campus is still far from complete, but an extreme reading of official statements during the last few weeks might suggest that it could be closed
FDA Ups Foreign Inspections In FY ’07; Visits 11% Of Foreign Establishments
FDA inspected more foreign drug establishments in fiscal 2007 than in each of the five previous years, but visited less than 11 percent of such facilities, the Government Accountability Office estimates in a report released Oct. 22